According to David Lassen, PharmD and Chief Clinical Officer at Prime, In the first year, its pretty conclusive that were not seeing any return from a total cost of care perspective
proposed that weight gain may represent an independent clinical feature of hyperprolactinemia, and reported a markedly increased prevalence of obesity in affected patients ( Consistent with these observations, several case series and retrospective reports have identified unexplained early weight gain, and in some cases, presentation of symptoms in patients later diagnosed with prolactinomas ( In a large retrospective analysis of 219 patients newly diagnosed with pathological hyperprolactinemia, Colao et al
Dosing solutions at known concentration were spiked into plasma or serum and used as standard
Microneedling with Serums Tiny needles create micro-channels in skin, allowing brightening serums (like vitamin C or tranexamic acid) to penetrate deeper
Front Pharmacol 13:910292 Bersuker K et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
It is an active regulatory system that influences appetite signaling, hormonal communication between the gut and brain, systemic inflammation, and energy balance
)
